EDGAR Filing Documents for 0001062993-13-006285

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001062993-13-006285

Filing Date

2013-12-11

Accepted

2013-12-11 17:32:42

Documents

Period of Report

2013-12-09

Document Format Files

Seq	Description	Document	Type	Size
1	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4.html	4
1	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4.xml	4	6576
	Complete submission text file	0001062993-13-006285.txt		7917

Mailing Address 35 WILBUR STREET LYNBROOK NY 11563

Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000

BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 167 EXECUTIVE DRIVE MANHASSET HILLS NY 11040

Business Address

Type: 4 | Act: 34 | File No.: 001-34236 | Film No.: 131271857